Lingying W. Huang
No.528. Zhangheng Road
Pudong, China
Pudong, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
ABCB1 rs2032582 as a potential biomarker for predicting Scutellaria baicalensis Georgi-drug induced liver injury in humans.
Journal: Journal of ethnopharmacology
Published: May 19, 2026
Congenital hepatic fibrosis in an adult female combined with Von Meyenburg complex and autosomal dominant polycystic kidney disease: a case report.
Journal: Frontiers in gastroenterology (Lausanne, Switzerland)
Published: May 09, 2026
Construction and validation of a predictive model for HBsAg loss in chronic hepatitis B patients treated with Peg-IFNα-2b.
Journal: Frontiers in cellular and infection microbiology
Published: April 25, 2026
Single-cell RNA sequencing unveils macrophage heterogeneity and cell-cell interactions in hepatocellular carcinoma progression.
Journal: Frontiers in genetics
Published: February 28, 2026
Randomised, controlled, crossover clinical trial protocol of puerarin for the treatment of metabolic-associated fatty liver disease in China.
Journal: BMJ open
Published: September 18, 2025
Ferroptosis in liver fibrosis and its potential intervention strategy.
Journal: Cell biology and toxicology
Published: June 14, 2025
The mechanisms and therapeutic potential of Atractylodes macrocephala Koidz in chronic liver disease management.
Journal: Journal of ethnopharmacology
Published: June 10, 2025
The application performance of MRI-PDFF detection values of different hepatic lobes in diagnosing liver steatosis.
Journal: Clinical and experimental medicine
Published: April 16, 2025
Potential use of serum microvesicle indicators to distinguish different types of drug-induced liver injury.
Journal: Journal of proteomics
Published: April 10, 2025
Optimized DWI-based virtual MR elastography for diagnosis and therapeutic monitoring of focal liver lesions.
Journal: European journal of radiology
Published: April 01, 2025
Exploring the Therapeutic Potential of TGF-β Inhibitors for Liver Fibrosis: Targeting Multiple Signaling Pathways.
Journal: Journal of clinical and translational hepatology
Published: January 16, 2025
Last Updated: 09/26/2026